NASDAQ · WEST

Westrock Coffee Company

$7.60 +$0.04 (+0.53%) 1D After hours

Key Metrics

$737.54M
Market cap
P/E · TTM
$1.28B
Revenue · TTM
−$71.76M
Net income
EPS · TTM $-0.76
Dividend yield
Free cash flow −$63.26M
Beta · 1Y 0.89
EBITDA · TTM $18.38M
Gross margin 13.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 6
    From its Jun 25 high, the share price fell 28%.

    Peak close $9.73 on Jun 25; trough close $6.99 on Jul 6. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -28%
  • Jun 29
    The stock moved -12.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 29
  • May 8
    The stock moved +39.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 8

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$737.54M
Enterprise value$1.11B
Shares outstanding97.6M
52-wk range$3.59 – $10.19
Avg volume · 20D318.6K
Net cash −$367.99M
Book value / share$-0.21
IndustryBeverages
ExchangeNASDAQ
About Westrock Coffee Company
IPO dateAug 29, 2022
Employees1393

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider mainly in the United States.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.57
P/FCF
EV/EBITDA60.16
EV/Sales0.86
Graham №

Profitability

Gross 13.0%
Operating -3.3%
Net -5.6%
FCF -4.9%
ROE / ROIC -185.8% · -11.9%

Financial Health

Current ratio0.97
Quick ratio0.46
Debt / equity-19.58
Debt / EBITDA 21.56
Net cash −$367.99M
Working capital−$9.92M

Cash Flow · TTM

Operating CF −$8.66M
Capex −$54.61M
Free cash flow −$63.26M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

0.8
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings